Roivant Sciences ROIV

NASDAQ ROIV

$41.73 +0.25 (+0.60%)

As of: Sep 9, 2026 · 12:40 PM EDT

Roivant Sciences (ROIV) Interest Coverage Ratio (QoQ) (2022 - 2023)

Analysis

Roivant Sciences (ROIV) Interest Coverage Ratio (QoQ) (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Amgen	211.37 Bn	197.38 Bn	7.24 Bn
2	Gilead Sciences	181.12 Bn	177.94 Bn	6.22 Bn
3	Vertex Pharmaceuticals	132.11 Bn	124.26 Bn	2.84 Bn
4	Regeneron Pharmaceuticals	82.51 Bn	74.52 Bn	3.93 Bn
5	Argenx Se	61.69 Bn	56.50 Bn	1.37 Bn
6	Moderna	54.62 Bn	49.48 Bn	52.00 Mn
7	Alnylam Pharmaceuticals	34.14 Bn	30.84 Bn	992.69 Mn
8	Biogen	31.29 Bn	30.01 Bn	1.96 Bn
9	Roivant Sciences	30.09 Bn	30.09 Bn	1.16 Mn
10	Insmed	28.32 Bn	27.16 Bn	358.27 Mn

Historic Data

Historic Data

Download Data

Date	Value
Dec 31, 2023	903.07%
Sep 30, 2023	25.42%
Dec 31, 2022	-44.07%
Sep 30, 2022	68.83%

Roivant Sciences

NASDAQ: ROIV

$41.73 ▲ +0.25 (+0.60%)

Sep 9, 2026 · 12:40 PM EDT